Australian Market Report for Orthopedic Growth Factors 2016 – MedCore

Australian Market Report for Orthopedic Growth Factors 2016 – MedCore


Growth factors are a group of small, soluble proteins that bind onto cell surface receptors, triggering a series of signals that regulate the body’s ability to grow, renew and heal. Due to the regenerative properties of growth factors, they have been exploited for bone healing in orthopedic applications.

  • Year: 2016
  • Scope: 2012-2022
  • Region: Australia
  • Published Date: 03/01/2016
  • Pages: 29
  • Type: MedCore

As of 2015, there have been three such products offered on the market in Australia: BMP-2-based INFUSE® by Medtronic, Olympus’s BMP-7-based OP-1® distributed by Stryker and Wright’s ?-TCP and rhPDGF-BB based Augment®.
BMPs were first discovered by Marshall Urist in 1965. Since the discovery, there have been 20 regulatory protein molecules identified to date. BMPs specifically regulate the production of bone within the human body. These proteins are functionally relevant during embryonic development in the formation of the skeleton. Urist established that demineralized bone matrix, when implanted in ectopic sites in rodents, helped to induce bone regeneration. Urist discovered that a single dose of BMP combined with autograft can repair non-union fractures that are 3 cm to 14 cm in size. BMPs are involved in many signaling pathways including those that cause increases in parathyroid hormone levels and the expression of osteocalcin, which stimulates osteoblast differentiation. These groundbreaking findings led to the isolation and cloning of several BMPs, which have been exploited for their healing properties.
Platelet-Derived Growth Factor (PDGF) is one of the first growth factors characterized and one of the most thoroughly studied molecules in the field of medicine. It is supported by a large base of scientific literature.

The "Australian Market Report Suite for Orthopedic Biomaterials 2016 - MedSuite" includes analysis on the following companies currently active in this market:
Bone Banks
DePuy Synthes
Emergo Asia Pacific
Genzyme (Sanofi)
Global Orthopaedic
LMT Surgical
Prism Surgical Designs
Scient'x Australia
Signature Orthopaedics
Smith & Nephew
Surgiplas Medical
Wright Medical
Zimmer Biomet

*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers